Metastasis Model of Cancer Stem Cell-Derived Tumors.
cancer stem cells
metastasis
surgery
transplantation
Journal
Methods and protocols
ISSN: 2409-9279
Titre abrégé: Methods Protoc
Pays: Switzerland
ID NLM: 101720073
Informations de publication
Date de publication:
21 Aug 2020
21 Aug 2020
Historique:
received:
21
07
2020
revised:
14
08
2020
accepted:
17
08
2020
entrez:
23
8
2020
pubmed:
23
8
2020
medline:
23
8
2020
Statut:
epublish
Résumé
Metastasis includes the dissemination of cancer cells from a malignant tumor and seed in distant sites inside the body forming secondary tumors. Metastatic cells from the primary tumor can move even before the cancer is detected. Therefore, metastases are responsible for more than 90% of cancer-related deaths. Over recent decades there has been adequate evidence suggesting the existence of CSCs with self-renewing and drug-resistant potency within heterogeneous tumors. Cancer stem cells (CSCs) act as a tumor initiating cells and have roles in tumor retrieve and metastasis. Our group recently developed a unique CSC model from mouse induced pluripotent stem cells cultured in the presence of cancer cell-conditioned medium that mimics tumors microenvironment. Using this model, we demonstrated a new method for studying metastasis by intraperitoneal transplantation of tumors and investigate the metastasis ability of cells from these segments. First of all, CSCs were injected subcutaneously in nude mice. The developed malignant tumors were minimized then transplanted into the peritoneal cavity. Following this, the developed tumor in addition to lung, pancreas and liver were then excised and analyzed. Our method showed the metastatic potential of CSCs with the ability of disseminated and moving to blood circulation and seeding in distant organs such as lung and pancreas. This method could provide a good model to study the mechanisms of metastasis according to CSC theory.
Identifiants
pubmed: 32825540
pii: mps3030060
doi: 10.3390/mps3030060
pmc: PMC7565080
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Challenging Exploratory Research
ID : 26640079
Organisme : Grant-in-Aid for Scientific Research (C)
ID : 16K07116
Références
Cancers (Basel). 2019 Mar 11;11(3):
pubmed: 30862050
Stem Cell Res Ther. 2015 Sep 16;6:178
pubmed: 26377541
Cancer Inform. 2016 Aug 16;15:163-78
pubmed: 27559294
Cancers (Basel). 2019 Dec 29;12(1):
pubmed: 31905766
Carcinogenesis. 2005 Mar;26(3):513-23
pubmed: 15358632
PLoS One. 2012;7(4):e33544
pubmed: 22511923
Medicine (Baltimore). 2016 Sep;95(1 Suppl 1):S20-5
pubmed: 27611935
Trends Cell Biol. 2013 Dec;23(12):603-11
pubmed: 23838335
Methods Protoc. 2019 Aug 16;2(3):
pubmed: 31426391
Crit Rev Oncog. 2013;18(1-2):43-73
pubmed: 23237552
Cell Syst. 2019 Aug 28;9(2):109-127
pubmed: 31465728
Mol Med Rep. 2017 Jun;15(6):3637-3643
pubmed: 28393208
Am J Cancer Res. 2016 Dec 01;6(12):2799-2815
pubmed: 28042501
J Cancer. 2014 Jul 05;5(7):572-84
pubmed: 25057308
Nat Rev Cancer. 2003 Jun;3(6):453-8
pubmed: 12778135
Bioengineering (Basel). 2019 Aug 23;6(3):
pubmed: 31450740